Project Number 3R61AT009628-01S1 Agency/Funding Organization NCCIH Funding Year 2018 View Full Project Details for Biological signatures of the cognitive effects of Centella asiatica Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator SOUMYANATH, AMALA Principal Investigator First Name AMALA Principal Investigator Last Name SOUMYANATH Awardee Organization OREGON HEALTH AND SCIENCE UNIVERSITY Awardee State Oregon Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-418: EXPLORATORY CLINICAL TRIALS AND STUDIES OF NATURAL PRODUCTS IN NCCIH HIGH PRIORITY RESEARCH TOPICS (R61/R33) FY Overall Cost $146,583 Funding Organization Agency/Funding Organization NCCIH Funding Organization Country United States Program Official WEBER, WENDY J Related Resources Clinical Trial Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment
